<DOC>
	<DOCNO>NCT02183051</DOCNO>
	<brief_summary>To assess analgesic efficacy tolerability meloxicam 15 mg , 7.5 mg , 3.75 mg 1.875 mg oral ( rapid release tablet ) compare placebo ibuprofen 400 mg 200 mg administer single dose , observation period 6 hour treatment pain surgery third molar .</brief_summary>
	<brief_title>Study Compare Analgesic Efficacy Tolerability Meloxicam Versus Placebo Ibuprofen Treatment Pain After Surgery Third Molar</brief_title>
	<detailed_description />
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Male female age 18 year Patients undergo removal one impacted mandibular third molar local anesthesia . ( Short duration anaesthetic allow , i.e . mepivacaine 3 % Italy Spain xylocaine USA , without vasoconstrictor ) Only patient type inclusion II IV include ( type II , molar submucosa ; type III , molar partially include bone ; type IV , molar fully include bone ) Assessment pain must least 50 mm 100 mm visual analogue scale ( VAS ) Patient inform consent accordance local legislation . Type I inclusion ( molar partially totally erupted ) Known suspect hypersensitivity trial drug excipients , analgesic , antipyretic nonsteroidal antiinflammatory drug ( NSAIDs ) Any clinical evidence active peptic ulceration last six month Recurrent ulcer Pregnancy breast feed Asthma , nasal polyp , angioneurotic oedema urticaria follow administration aspirin NSAIDs Concomitant treatment anticoagulant ( include heparin ) , lithium Concomitant administration anti inflammatory analgesic agent Administration drug analgesic property 24 h previous administration study drug , except local anesthetic surgery Administration antibiotic Significant perioperative complication judge oral surgeon Clinical evidence know severe cardiac , hepatic , renal , metabolic , hematological disease ( include bleed disorder ) , mental disturbance , ulcerative colitis Any disease could interfere evaluation efficacy safety Participation another clinical trial study previous month Previous participation trial Patient unable comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>